October 15, 2025

Eco-friendly silicon patch delivers clearer ultrasound images without harmful lead components

October 15, 2025 / Research update / InnovateMed Author / silicon patch

by National Research Council of Science and Technology edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Example of daily-life application of the eco-friendly silicon nanocolumn-based disposable ultrasound patch. Credit: Korea Institute of Science and Technology Wearable ultrasound devices are actively used in various medical settings, including hospital diagnostics, rehabilitation monitoring, and telemedicine. However, most commercial devices […]

Eco-friendly silicon patch delivers clearer ultrasound images without harmful lead components Read More »

Optical imaging technique unlocks hidden glycemic history for diabetes and cancer research

October 15, 2025 / Research update / InnovateMed Author / optical imaging

by National Taiwan University edited by Lisa Lock, reviewed by Robert Egan Editors’ notes National Taiwan University researchers have developed a new imaging technology, color-resolved third-harmonic-generation microscopy (cTHGM), that noninvasively measures glycated hemoglobin in individual red blood cells. This breakthrough enables retrospective reconstruction of a person’s blood sugar history, opening new possibilities for diabetes management and early cancer

Optical imaging technique unlocks hidden glycemic history for diabetes and cancer research Read More »

Human liver organoid platform can predict immune-mediated drug toxicity

October 15, 2025 / Research update / InnovateMed Author / human liver

October 14, 2025 The GIST by Cincinnati Children’s Hospital Medical Center edited by Gaby Clark, reviewed by Robert Egan Editors’ notes Example of human liver organoids co-cultured with autologous CD8 T cells (green). These tissues can be used during drug development to predict liver toxicity, according to new resaerch published by experts at Cincinnati Children’s. Credit: Cincinnati Children’s

Human liver organoid platform can predict immune-mediated drug toxicity Read More »

New gene therapy shows promise in preventing kidney disease in type 1 diabetes

October 15, 2025 / Research update / InnovateMed Author / type 1 diabetes

by University of Bristol edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a University of Bristol study. One in three people with

New gene therapy shows promise in preventing kidney disease in type 1 diabetes Read More »

New research identifies more accurate way of predicting which blood cancer patients will relapse early

October 15, 2025 / Research update / InnovateMed Author / blood cancer

by Institute of Cancer Research edited by Lisa Lock, reviewed by Andrew Zinin Editors’ notes Credit: CC0 Public Domain A study carried out by a team of researchers from The Institute of Cancer Research, London, found that combining two types of genetic tests gives doctors a much better chance of identifying multiple myeloma patients who are at risk

New research identifies more accurate way of predicting which blood cancer patients will relapse early Read More »

Cardamom seeds revealed as potential source of antiviral treatment

October 15, 2025 / Research update / InnovateMed Author / antiviral treatment

by Shinshu University edited by Gaby Clark, reviewed by Robert Egan Editors’ notes The antiviral effects of cardamom seed (Elettaria cardamomum) extract through enhanced type I interferon production were revealed in this study. Credit: Abdullah Al Sufian Shuvo from Shinshu University, Japan Plant-based materials have traditionally been used to treat a variety of viral infections. Now, researchers have

Cardamom seeds revealed as potential source of antiviral treatment Read More »

Immunotherapy approach offers hope for long-term HIV control without daily medication

October 15, 2025 / Research update / InnovateMed Author / HIV control

by Fabienne Landry, McGill University edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Scanning electromicrograph of an HIV-infected T cell. Credit: NIAID HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and preventing illness, but they are not

Immunotherapy approach offers hope for long-term HIV control without daily medication Read More »

Research paves the way for potential anti-ulcer vaccine

October 15, 2025 / Research update / InnovateMed Author / ulcer vaccine

by Timothy James M. Dimacali, Ateneo de Manila University edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Ateneo researchers used computer software and computational techniques aimed at studying the immune system—a process called “immunoinformatics”—to analyze how the human body responds to various proteins produced by H. pylori. Credit: Chacon et al., 2025 Since ancient times, it

Research paves the way for potential anti-ulcer vaccine Read More »

Stem cell advances could boost regeneration and plasticity of brain neurons

October 15, 2025 / Research update / InnovateMed Author / regeneration

by University of Barcelona edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Overexpression of BDNF in human iPSC-derived NPCs expressing a calcium indicator. Credit: International Journal of Molecular Sciences (2025). DOI: 10.3390/ijms26157262 The brain’s mechanisms for repairing injuries caused by trauma or degenerative diseases are not yet known in detail. Now, a study from the University of Barcelona

Stem cell advances could boost regeneration and plasticity of brain neurons Read More »

Novel combination therapy shows promise for aggressive lymphoma resistant to immunotherapy

October 15, 2025 / Research update / InnovateMed Author / aggressive lymphoma

by American Association for Cancer Research edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: SHVETS production from Pexels A study published in Cancer Discovery finds that combining an epigenetic therapy with an anti-PD-1 antibody, which uses the body’s natural response to viral infections, shows promising results in patients with relapsed or refractory natural killer/T-cell lymphoma (R/R NKTL),

Novel combination therapy shows promise for aggressive lymphoma resistant to immunotherapy Read More »